Hoth Therapeutics Inc. (NASDAQ:HOTH) Stock Continues to Trade in a Narrow

November 9, 2021

Hoth Therapeutics Inc. (NASDAQ:HOTH) is in a range. The company has signed two agreements with SuXi AppTec’s subsidiary STA Pharmaceutical to establish and produce a formulating and active pharmaceutical ingredient of drug product for ongoing development and marketing of HT-KIT. Trading Data On Monday, HOTH stock jumped 1% at $1.11 with more than 830k shares, compared to its average volume of 395K shares. The stock has moved within a range…


Hoth Therapeutics Inc (NASDAQ: HOTH) Announce Positive Results From HT-003 Assets Group

July 15, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) announced that the HT-003 assets group had fetched positive results in the therapeutic model for Vivo acne. The model displayed HT-003’s capability in bringing down the expression for receptor 2 (TLR2), which is among the most significant pathways meant for acne pathophysiology.  About the study results Additionally, the study underscored HT-003’s capability in bringing down the cytokines’ expression, which is helpful for acne pathophysiology. These…